Symeres

Symeres is a leading contract research organization (CRO) specializing in drug discovery, development, and custom synthesis services.

With over 30 years of experience, Symeres supports the biotech and pharma sectors in drug discovery and development. They operate across Europe and the US, employing over 600 scientists. The company offers a wide array of services, ranging from early-stage hit finding to GMP manufacturing, enabling clients to progress their drug pipelines efficiently and effectively.

Key products and services:

• Drug discovery (hit generation, hit-to-lead, lead optimization)
• Synthetic chemistry (custom synthesis, enabling technologies, and specialty chemistries)
• Drug development (non-GMP scale-up, GMP manufacturing, formulation development)
• ADME-Tox (physicochemistry, metabolism studies, and safety pharmacology)

Symeres prides itself on its collaborative approach, working closely with clients to overcome challenges in drug development. Their adaptability, expertise, and strong track record have made them a trusted partner for biotech and pharmaceutical companies worldwide.